These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4992995)

  • 21. Studies on antitumor agents. II. Antitumor activity of 5-amino-4-imidazolethiocarboxamide derivatives on a variety of animal tumors.
    Hoshi A; Kanzawa F; Kumagai K; Kuretani K
    Cancer Chemother Rep; 1969 Jun; 53(3):165-8. PubMed ID: 5807478
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biological action of butylated hydroxytoluene (literature review)].
    Gor'kov VA; Disvetova VV; Evseenko LS; Matveeva SA
    Vopr Pitan; 1970; 29(4):65-72. PubMed ID: 4923708
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
    Saczewski F; Maruszak M; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imidazole and pyrazole bis(2-fluoroethyl)triazenes.
    Shealy YF; O'Dell CA
    J Pharm Sci; 1970 Sep; 59(9):1358-60. PubMed ID: 5469811
    [No Abstract]   [Full Text] [Related]  

  • 25. Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agents.
    Paul R; Brockman JA; Hallett WA; Hanifin JW; Tarrant ME; Torley LW; Callahan FM; Fabio PF; Johnson BD; Lenhard RH
    J Med Chem; 1985 Nov; 28(11):1704-16. PubMed ID: 2415706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aryl-2-halogenoalkylamines. XXIV. Derivatives of o-, m- and p-aminophenol: synthesis and antineoplastic activities.
    Artico M; Ross WC
    Biochem Pharmacol; 1968 Jun; 17(6):893-8. PubMed ID: 5661352
    [No Abstract]   [Full Text] [Related]  

  • 27. Antihypertensive agents. Synthesis and biological properties of 2-amino-4-aryl-2-imidazolines.
    Matier WL; Owens DA; Comer WT; Deitchman D; Ferguson HC; Seidehamel RJ; Young JR
    J Med Chem; 1973 Aug; 16(8):901-8. PubMed ID: 4745833
    [No Abstract]   [Full Text] [Related]  

  • 28. Irreversible enzyme inhibitors. 197. Water-soluble reversible inhibitors of dihydrofolate reductase with potent antitumor activity derived from 4, 6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine.
    Baker BR; Ashton WT
    J Med Chem; 1973 Mar; 16(3):209-14. PubMed ID: 4733101
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and biological activity of some 2-aminoimidazoles.
    Cavalleri B; Volpe G; Arioli V; Parenti F
    Arzneimittelforschung; 1977; 27(10):1889-95. PubMed ID: 579099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PHARMACOLOGICAL STUDIES OF SEVERAL NEW ANTITUMOUR AGENTS.
    HSU B; KAO YS; TSAI JS; CHOU CH; LIU MC; SHEN ML; OWEN TY; JEN YF; PAN PC; LI SW
    Sci Sin; 1964 May; 13():789-800. PubMed ID: 14170539
    [No Abstract]   [Full Text] [Related]  

  • 31. Cobalt chelates of Schiff bases of aromatic amines as antitumor agents.
    Hodnett EM; Moore CH
    J Med Chem; 1971 Nov; 14(11):1121-3. PubMed ID: 5115217
    [No Abstract]   [Full Text] [Related]  

  • 32. Irreversible enzyme inhibitors. 196. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine and bearing a terminal phenyl sulfonate group.
    Baker BR; Ashton WT
    J Med Chem; 1972 Sep; 15(9):945-7. PubMed ID: 5051014
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor-inhibitory effect of a streptococcal preparation (NSC-B116209).
    Tsukagoshi S; Sakurai Y; Sato H; Akiba T SUZUKI S
    Cancer Chemother Rep; 1972 Feb; 56(1):9-17. PubMed ID: 4337882
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis and biological activity studies of 1,3,4-thiadiazolo[2,3-c]-as-triazines.
    Kalluraya B; Sreenivasa S; Banji D
    Boll Chim Farm; 1997 Mar; 136(3):266-71. PubMed ID: 9164168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-amino-5-nitroimidazoles.
    Miller LF; Bambury RE
    J Med Chem; 1971 Dec; 14(12):1217-8. PubMed ID: 5165606
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary cancer of liver.
    Cole DR; Befeler D
    N Y State J Med; 1970 Jul; 70(13):1789-92. PubMed ID: 4317155
    [No Abstract]   [Full Text] [Related]  

  • 37. An efficient and expeditious synthesis of di- and monosubstituted 2-aminoimidazoles.
    Soh CH; Chui WK; Lam Y
    J Comb Chem; 2008; 10(1):118-22. PubMed ID: 18159933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syntheses, antitumor activity and vascular relaxing effect of purino[7,8-g]-6-azapteridines and [1,2,4]triazino-[3,2-f]purines.
    Ueda T; Adachi T; Sakakibara J; Asano M; Nakagami J
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4031-8. PubMed ID: 3435936
    [No Abstract]   [Full Text] [Related]  

  • 39. [Problems specific to chemotherapy of intracerebral tumors].
    Hirsch JF
    Neurochirurgie; 1974; 20(3):233-46. PubMed ID: 4219038
    [No Abstract]   [Full Text] [Related]  

  • 40. Irreversible enzyme inhibitors. 173. Cure of Walker 256 ascites by reversible and irreversible inhibitors of dihydrofolic reductase derived from 1-(substituted-phenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR; Vermeulen NM; Ashton WT; Ryan AJ
    J Med Chem; 1970 Nov; 13(6):1130-40. PubMed ID: 5479852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.